Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2006
07/11/2006US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
07/11/2006US7074800 Quinazoline derivatives as angiogenesis inhibitors
07/11/2006US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity
07/11/2006US7074795 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
07/11/2006US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor
07/11/2006US7074789 Kinase inhibitors
07/11/2006US7074787 Controlling, prevention plant infections; fungicides, nematocides, insecticides
07/11/2006US7074785 Δ1-pyrrolines used as pesticides
07/11/2006US7074784 Medicaments against viral diseases
07/11/2006US7074783 Analgesics; central nervous system disorders; asthma; rhinitis; antiarthritic agents; inflammatory bowel disorders
07/11/2006US7074780 Substituted phenylcyclohexanecarboxamides and their use
07/11/2006US7074534 Polymeric charge transport compositions and electronic devices made with such compositions
07/11/2006CA2367306C New cycloheptene compounds, their preparation process and the pharmaceutical compounds containing them
07/11/2006CA2285548C Nicotinamide derivatives
07/11/2006CA2274074C Novel compounds with analgesic effect
07/11/2006CA2269810C N-substituted 2-cyanopyrrolidines
07/11/2006CA2260999C Heterocyclic compounds, their production and use in tyrosine kinase inhibition
07/11/2006CA2227984C Aza-anthracyclinone derivatives
07/11/2006CA2206532C Novel amidinonaphthyl derivative or salt thereof
07/11/2006CA2168447C Compounds and methods for inhibition of hiv and related viruses
07/11/2006CA2163244C Quinoline derivatives as leukotriene antagonists
07/11/2006CA2158609C 5 .alpha.-reductase inhibitors
07/06/2006WO2006071958A1 Compounds useful as chemokine receptor antagonists
07/06/2006WO2006071130A2 A process for preparation of imatinib base
07/06/2006WO2006070878A1 Carboxylic acid derivative or salt thereof
07/06/2006WO2006070806A1 Novel benzimidazole compound and medicinal composition containing the compound
07/06/2006WO2006070284A1 Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors
07/06/2006WO2006070208A1 Pyridine, pyrimidine and pyrazine derivatives as gpcr agonists
07/06/2006WO2006070198A1 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
07/06/2006WO2006070001A1 Substituted indole ligands for the orl-1 receptor
07/06/2006WO2006069809A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments
07/06/2006WO2006069788A1 Organic compounds
07/06/2006WO2006069776A1 5-ht7 receptor antagonists
07/06/2006WO2006069775A1 5-ht7 receptor antagonists
07/06/2006WO2006069525A1 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
07/06/2006WO2006069441A1 Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases
07/06/2006WO2006053274A3 2-amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
07/06/2006WO2006051374A3 Arylpiperazines useful as adrenergic receptor antagonists
07/06/2006US20060149092 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
07/06/2006US20060149072 Selective to alpha2B or alpha2C adrenergic receptors, minimal cardivascular or sedatory activity; treating visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion
07/06/2006US20060149071 Hydrolyzing the ester group of an alkylated 4-amino-4-carboxyamino-piperidine compound and treating the piperidine hydrolysis product with a hydride to produce a 4-hydroxymethyl-piperidine; method requires fewer steps and produces a greater yield of product than known methods; synthetic opioids
07/06/2006US20060149066 Imidazole derivatives
07/06/2006US20060149059 Phthalazinone derivatives
07/06/2006US20060148872 2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one
07/06/2006US20060148862 Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
07/06/2006US20060148860 Substituted p-phenyl carbamates
07/06/2006US20060148858 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity
07/06/2006US20060148857 Tetrahydrocarbazole derivatives and their pharmaceutical use
07/06/2006US20060148856 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
07/06/2006US20060148855 Carboxamide derivatives
07/06/2006US20060148854 Chemical compounds
07/06/2006US20060148850 4-{'3-(Sulfonylamino) phenyl!'1-(cyclymethyl) piperidin-4-ylidene! methyl}benazmide derivativess as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder
07/06/2006US20060148845 In which a pyrrole ring is directly bonded to a 6,5-condensed ring system, such as a benzimidazole, imidazopyridine or imidazopyrimidine system; especially effective against drug resistant bacteria such as MRSA, PRSP, or VRE
07/06/2006US20060148824 Administering compounds such as 6-Chloro-N-[(1R)-1-phenylethyl]pyrazin-2-amine for inhibiting a protein kinase
07/06/2006US20060148823 Tricyclic delta -opioid modulators; 10-(1-Benzyl-piperidin-4-yl)-6-hydroxy-10H-phenoxazine-3-carboxylic acid diethylamide; immunosuppressants, antiinflammatory agents, depression, Parkinson's disease; reduced side effects; veterinary composition to treat mild to severe pain in warm-blooded animals
07/06/2006US20060148819 Chemical compounds
07/06/2006US20060148818 Novel tetraydrospiro(piperdine-2,7'- pyrrolo{3,2-b}pyridine derivatives and novel in-dole derivatives useful in the treatment of 5-ht6 receptor-related disorders
07/06/2006US20060148817 Pyrazole compounds
07/06/2006US20060148816 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
07/06/2006US20060148815 4-Phenyl-1-piperazinyl, -piperidinyl and-tetrahydropyridyl derivatives
07/06/2006US20060148814 4-(2-Pyridyl)-1-amino(thio)carbonylpiperazine derivatives are antagonists of the mGluR5 receptor
07/06/2006US20060148809 For the therapy of deleterious neurological complaints; anxiolytic agents;cognitive disorders; good affinity as ligands for the alpha 2 and or alpha 3 and or alpha 5 subunit of the human GABAA receptor; 3-(6-Phenylpyridazin-4-yl)thiophene-2-carboxylic Acid Methyl Ester
07/06/2006US20060148794 Neuropeptide Y antagonist; antiarthritic agents; cardiovascular disorders; antidiabetic agents; kidney disorders; eating disorders; obesity
07/06/2006US20060148792 Substituted 1,4-benzodiazepines and uses thereof
07/06/2006US20060148791 Glutamate receptor antagonists
07/06/2006US20060148780 Diazepanes derivatives useful as ifa inhibitors
07/06/2006US20060148779 Calcitonin Gene-Related Peptide (CGRP) antagonists for migraine and cluster headaches; 5'-acylamino-spiro[imidazolidine-4,2'-indane]-2,5-dione derivatives
07/06/2006US20060148764 5-phenypyrimidines their preparation compositions comprising them and their use
07/06/2006US20060148649 Substituted n-aryl nitrogen heterocycles
07/06/2006US20060147747 2-[4-(10-naphthalene-2-yl-anthracene-9-yl)-phenyl]-1-phenyl-1H-benzimidazole; elevation of luminance and of efficiency in light emission even under low driving voltage
07/06/2006DE102004061748A1 Azetidin-substituierte Pyrazoline Azetidine-substituted pyrazolines
07/06/2006CA2594251A1 Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors
07/06/2006CA2592858A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments
07/06/2006CA2592514A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
07/06/2006CA2591201A1 5-ht7 receptor antagonists
07/06/2006CA2590666A1 5-ht7 receptor antagonists
07/06/2006CA2590586A1 Substituted biaryl analogues
07/06/2006CA2587348A1 Organic compounds
07/05/2006EP1676846A2 Hydantoin derivatives as MMP inhibitors
07/05/2006EP1676845A1 New quinazoline derivatives
07/05/2006EP1676844A1 5-HT7 receptor antagonists
07/05/2006EP1676843A1 Substituted indole ligands for the ORL-1 receptor
07/05/2006EP1676841A1 Substitited indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their prepartion and use in medicaments
07/05/2006EP1676840A1 5-HT7 Receptor antagonists
07/05/2006EP1675856A1 Novel tetraydrospiro{piperidine-2,7'-pyrrolo [3,2]pyridine} derivatives and novel indole derivatives useful in the treatment of 5-ht6 receptor -related disorders
07/05/2006EP1675852A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
07/05/2006EP1675849A1 Benzimidazolyl derivatives
07/05/2006EP1675848A1 Novel triarylimidazoles
07/05/2006EP1675847A2 Spirocyclic heterocyclic derivatives and methods of their use
07/05/2006EP1675846A1 Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1h- [1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
07/05/2006EP1675845A2 Glutamine fructose-6-phosphate amidotransferase (gfat) inhibitors
07/05/2006EP1675838A1 1-benzoyl substituted diazepine derivatives as selective histamine h3 receptor agonists
07/05/2006EP1675836A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy
07/05/2006EP1675835A1 Methods of preparation of dehydro-diketopiperazines in liquid phase or of solid supported phase
07/05/2006EP1675832A1 Heterocyclyl compounds
07/05/2006EP1675826A1 Compounds having crth2 antagonist activity
07/05/2006EP1675594A2 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
07/05/2006EP1675593A1 Process for making sterile aripiprazole of desired mean particle size
07/05/2006EP1675585A2 Large conductance calcium-activated k channel opener
07/05/2006EP1675584A1 Substituted benzazoles and use thereof as inhibitors of raf kinase